| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 9 | |
| #2 | Australia | 2 | |
| #3 | Japan | 2 | |
| #4 | Brazil | 1 | |
| #5 | Israel | 1 | |
| #6 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology | |
| #3 | Biotechnology | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Climate change adaptation technologies | |
| #5 | Diagnosis and surgery | |
| #6 | Syringes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Glenn Gregory M | 6 |
| #2 | Glenn Gregory | 5 |
| #3 | Six Howard R | 3 |
| #4 | Moncrief J Scott | 3 |
| #5 | Wilkins Tracy D | 3 |
| #6 | Lylerly David M | 3 |
| #7 | Ellingsworth Larry | 3 |
| #8 | Phelps Carol | 3 |
| #9 | Zheng Limin | 3 |
| #10 | Fuhrmann Steven | 2 |
| Publication | Filing date | Title |
|---|---|---|
| AU2011298306A1 | Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof | |
| EP1708744A2 | Gm1 binding deficient exotoxins for use as immunoadjuvants | |
| AU2002252378B2 | Transcutaneous immunostimulation |